| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC15 |
| UNII: | 640443FU93 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-6 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Giant Cell Arteritis | 3 | D013700 | ClinicalTrials |
| Polymyalgia Rheumatica | 3 | D011111 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
| Lupus Erythematosus, Cutaneous | 1 | D008178 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1194585-53-9 |
| ChEMBL | CHEMBL1743071 |
| FDA SRS | 640443FU93 |
| Guide to Pharmacology | 7989 |
CONTENTS